Article Information
History
- October 5, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hanyun Yang, MD#,
- Xinran Liu, MM#,
- Lijuan Wang, MD#,
- Wenlan Zhou, MD,
- Ying Tian, MD,
- Ye Dong, MM,
- Kemin Zhou, BSC,
- Li Chen, MSN,
- Meng Wang, MSC and
- Hubing Wu, MD, PhD*
- GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China
- ↵*Corresponding author:
Hubing Wu, MD, PhD, Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, 1838 Guangzhou North Road, Guangzhou, Guangdong Province, 510515, China. Phone: +86 020 62787317 (Hubing Wu), E-mail addresses: wuhbym{at}163.com (Hubing Wu)
↵# Contributed equally to this work.
Posted October 05, 2023.
18F-FDG PET/CT characteristics of IASLC grade 3 invasive adenocarcinoma and the value of 18F-FDG PET/CT for preoperative prediction
